Lunai Bioworks Inc.
LNAI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $3 | $4 | $8 |
| G&A Expenses | $18 | $25 | $15 | $14 |
| SG&A Expenses | $18 | $25 | $15 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $171 | $54 | $19 | $93 |
| Operating Expenses | $189 | $82 | $39 | $116 |
| Operating Income | -$189 | -$82 | -$39 | -$116 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $11 | -$7 | -$1 | $3 |
| Pre-Tax Income | -$178 | -$88 | -$40 | -$113 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$178 | -$88 | -$40 | -$113 |
| % Margin | – | – | – | – |
| EPS | -10.78 | -9.1 | -7.1 | -21.6 |
| % Growth | -18.5% | -28.2% | 67.1% | – |
| EPS Diluted | -10.78 | -9.1 | -7.1 | -21.6 |
| Weighted Avg Shares Out | 17 | 10 | 6 | 5 |
| Weighted Avg Shares Out Dil | 17 | 10 | 6 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$177 | -$86 | -$39 | -$113 |
| % Margin | – | – | – | – |